Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003Astri Fjelde Maaland, Jostein Dahle, Tania A. Rozgaja Stallons et al.|PLoS ONE|2020Cited by 39
Abstract 5432: Targeted alpha therapy with 212Pb-NNV003 in treatment of NHLJostein Dahle, Julien Torgue, Amal Saidi et al.|Cancer Research|2022Cited by 1